Skip to main content
NIBEC CO., LTD. logo

NIBEC CO., LTD. — Investor Relations & Filings

Ticker · 138610 ISIN · KR7138610001 KO Manufacturing
Filings indexed 218 across all filing types
Latest filing 2019-03-11 Proxy Solicitation & In…
Country KR South Korea
Listing KO 138610

About NIBEC CO., LTD.

https://nibec.co.kr/en/

NIBEC CO., LTD. is a biotechnology company specializing in the research, development, and commercialization of healthcare solutions centered on proprietary peptide technology. The company's core activities involve the manufacturing of tissue regenerative biomaterials, such as dental bone grafts and collagen-based products, as well as biomaterial-based medical devices. In addition to its focus on regenerative medicine, NIBEC develops and markets a range of dental care and cosmetic products. The company is also actively engaged in the research and development of novel peptide-based drugs and bio-fusion technologies to address various therapeutic needs.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal 'Notice of Annual General Meeting' (주주총회소집공고) for Nibec Co., Ltd. It contains the meeting agenda, details on voting procedures (including electronic voting), and management's report on financial statements and proposed changes to the articles of incorporation. This document is a standard proxy statement/notice sent to shareholders to solicit their participation and votes for the upcoming AGM.
2019-03-11 Korean
수시공시의무관련사항(공정공시)(치과용 골재생 바이오소재 및 콜라겐 바이오소재 등 품목계약의 건)
Regulatory Filings Classification · 95% confidence The document is a 'Fair Disclosure' (공정공시) filing from the company NIBEC regarding a product supply contract with Straumann. It details the contract terms, duration, and financial scale. Since this is a specific regulatory disclosure regarding a material business contract that does not fit into the other specialized categories like M&A or Share Issues, it falls under the general regulatory filing category.
2019-02-22 Korean
주권매매거래정지(단일판매공급계약)
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding the suspension of stock trading for the company (주)나이벡 due to a single sales supply contract. It cites specific KOSDAQ market regulations and provides the duration of the suspension. Since it is a regulatory announcement regarding market operations and does not fit into specific categories like M&A or financial reports, it is classified as a general regulatory filing.
2019-02-20 Korean
단일판매ㆍ공급계약해지
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure from a Korean company (NIBEC) regarding the termination of a single sales and supply contract. It details the contract termination amount, the counterparty, the reason for termination, and the date. Since this is a specific regulatory announcement regarding a material business event (contract termination) that does not fit into categories like financial reports, dividends, or director dealings, it falls under the general regulatory filing category.
2019-02-19 Korean
전환가액의조정(제5회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (5th series) issued by the company 'NIBEC'. It details the change in conversion price, the number of convertible shares, the reason for the adjustment (market price decline), and the calculation methodology. This type of disclosure regarding capital structure changes, specifically related to convertible debt instruments, falls under the 'Capital/Financing Update' category.
2018-12-26 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 90% confidence The document is a short regulatory announcement regarding the closure of the shareholder register for the purpose of determining shareholders eligible to vote at the upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal regulatory notice of a corporate action. Given the nature of the announcement (shareholder register closure for a meeting), it fits best under the general regulatory filing category as it is a specific corporate administrative notice.
2018-12-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.